Atlas Trials

Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes

Clinical trial NCT00925119 · TERMINATED

Trial details

NCT number
NCT00925119
Sponsor
University of Maryland, Baltimore
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2009-12-01
Primary completion
2013-06-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.